🔴 Biomea Fusion is trading 11.18% down today after terminating proposed public offering

Biomea Fusion is trading 11.18% down at $1.51 after terminating its proposed public offering on September 23, 2026.

• Management said market conditions were not favorable enough to offer securities on terms that would benefit shareholders.
• No securities were sold.
• The abrupt launch and termination have focused investors on dilution and financing concerns, pressuring shares despite a broader biotech sector rally.